0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV42.56%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma17.41Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Synchronoss Technologies Stock Discussion
Synchronoss Launches Enhanced Version of Personal Cloud Solution at CES 2025 Purpose-Built for Service Providers
Tuesday, 7th January at 8:05 am
BRIDGEWATER, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. ("Synchronoss" or the "Company") (NASDAQ: SNCR), a global leader and innovator in personal cloud platforms, today announced the launch of the next-generation Synchronoss Personal Cloud™ platform at CES 2025 in Las Vegas.
Availabl...
Synchronoss Announces Three-Year Contract Extension with Major U.S Telecom Provider
Synchronoss Technologies (NASDAQ: SNCR) has secured a three-year contract extension with a major U.S. telecom provider for its Personal Cloud platform. The platform enables subscribers to securely backup, manage, and share content across devices. The latest version integrates AI functionality, offering enhanced capabilities for digital content management.
The Synchronoss Pe...
👀
In reaction to earnings/guidance:
• $Thor Industries (THO.US)$ +2.5%
Other news:
• $Acumen Pharmaceuticals (ABOS.US)$+76.8% (in response with BIIB)
• $Biogen (BIIB.US)$ +45.6% (reports Lecanemab confirmatory Phase 3 Clarity AD study met primary endpoint)
• $Nano X Imaging (NNOX.US)$+22.8% (submitted a 510(k) premarket notification to the FDA on Sept 26 for its multisource 3D digital tomosynthesis system)
• $Ocugen (OCGN.US)$ +9.3% (en...
No comment yet